{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:15Z","timestamp":1791229455821,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vhri.2021.06.008","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T23:28:17Z","timestamp":1637191697000},"page":"16-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Validating the \u201cTreatment Satisfaction Questionnaire for Medication\u201d in Persian and Evaluating Treatment Satisfaction Among Patients With Psoriasis"],"prefix":"10.1016","volume":"29","author":[{"given":"Alireza","family":"Abdshah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Parsaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vhri.2021.06.008_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOR.0000000000000358","article-title":"Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?","volume":"29","author":"Alexander","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.vhri.2021.06.008_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1590\/abd1806-4841.20165080","article-title":"Psoriasis comorbidities: complications and benefits of immunobiological treatment","volume":"91","author":"Carvalho","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"8","key":"10.1016\/j.vhri.2021.06.008_bib3","first-page":"25","article-title":"New oral therapies for psoriasis: a comprehensive review","volume":"9","author":"Goldenberg","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.vhri.2021.06.008_bib4","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2147\/PPA.S117006","article-title":"Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature","volume":"10","author":"Belinchon","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"10.1016\/j.vhri.2021.06.008_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2340\/00015555-2011","article-title":"Treatment satisfaction of patients with psoriasis","volume":"95","author":"Schaarschmidt","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.vhri.2021.06.008_bib6","first-page":"26","article-title":"Treatment satisfaction among patients with moderate-to-severe psoriasis","volume":"8","author":"Finch","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.vhri.2021.06.008_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2147\/PPA.S85773","article-title":"Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis","volume":"9","author":"Zhang","year":"2015","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.008_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjd.12745","article-title":"Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice","volume":"170","author":"Callis Duffin","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.vhri.2021.06.008_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/09546634.2012.697112","article-title":"Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study","volume":"24","author":"Christophers","year":"2013","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.008_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.12372","article-title":"Satisfaction with treatment among patients with psoriasis: a web-based survey study","volume":"169","author":"Van Cranenburgh","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.vhri.2021.06.008_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1684\/ejd.2013.1988","article-title":"Patient benefit index (PBI) in the treatment of psoriasis--results of the National Care Study \u201cPsoHealth\u201d","volume":"23","author":"Radtke","year":"2013","journal-title":"Eur J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2021.06.008_bib12","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","article-title":"Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumers","volume":"8","author":"Atkinson","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2021.06.008_bib13","series-title":"Medical Statistics: A Guide to SPSS, Data Analysis, and Critical Appraisal","author":"Barton","year":"2014"},{"issue":"1","key":"10.1016\/j.vhri.2021.06.008_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12955-014-0176-2","article-title":"Sample size used\u00a0to validate a scale: a review of publications on newly-developed patient-reported outcomes measures","volume":"12","author":"Anthoine","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.vhri.2021.06.008_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3102\/10769986027004335","article-title":"Sample size requirements for testing and estimating coefficient alpha","volume":"27","author":"Bonett","year":"2002","journal-title":"J Educ Behav Stat"},{"key":"10.1016\/j.vhri.2021.06.008_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vhri.2018.01.007","article-title":"Treatment satisfaction questionnaire for medication: validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia","volume":"16","author":"Shilbayeh","year":"2018","journal-title":"Value Health Reg Issues"},{"issue":"10","key":"10.1016\/j.vhri.2021.06.008_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","article-title":"Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.vhri.2021.06.008_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","article-title":"Patient perspectives in the management of psoriasis: results from the population-based multinational assessment of Psoriasis and Psoriatic Arthritis Survey","volume":"70","author":"Lebwohl","year":"2014","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.vhri.2022.08.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109921000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109921000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:12:51Z","timestamp":1761941571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109921000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":18,"alternative-id":["S2212109921000984"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2021.06.008","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validating the \u201cTreatment Satisfaction Questionnaire for Medication\u201d in Persian and Evaluating Treatment Satisfaction Among Patients With Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2021.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}